Skip to content

Oxytocin and attachment development: Looking beyond the expected?

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518004-49-00
Enrollment
200
Registered
2024-12-17
Start date
2025-10-28
Completion date
Unknown
Last updated
2024-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy children

Brief summary

To assess whether oxytocin affects cognitive flexibility, we will analyze perseverative errors during the PRLT and compare these errors in children that received oxytocin vs. children that received the placebo. We expect that oxytocin will attenuate learning during this test. More specifically, children that receive oxytocin will make more perseverative errors than children who received the placebo., To assess the effect of oxytocin on trust behaviour, we will analyze the changes in self-reported trust (computing a difference score comparing trust after the baseline vs. after the test. We expect to find less trust behavior decrease after the test block in the 80% baseline block condition for children who receive oxytocin (Study 1). For the other children, we predict stronger decreases in trust behavior (Study 1)., To assess the effect of oxytocin on trust behaviour, we will analyze the changes in self-reported trust (computing a difference score comparing trust after the baseline vs. after the test. We expect to find less trust behavior increase after the test block in the 20% baseline block condition for children who receive oxytocin (Study 2). For the other children, we predict stronger increases in trust behavior (Study 2)., To assess whether oxytocin attenuates dopamine responses, we will test between subsequent trials whether oxytocin decreases the negative impact of prediction error on decreases in attentional preference for mother after prediction error trials. For this purpose, we will compare performance on prediction error trials versus trials without prediction error.

Interventions

DRUGNaCl 0.9% nose drops

Sponsors

UZ Leuven
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Design outcomes

Primary

MeasureTime frame
To assess whether oxytocin affects cognitive flexibility, we will analyze perseverative errors during the PRLT and compare these errors in children that received oxytocin vs. children that received the placebo. We expect that oxytocin will attenuate learning during this test. More specifically, children that receive oxytocin will make more perseverative errors than children who received the placebo., To assess the effect of oxytocin on trust behaviour, we will analyze the changes in self-reported trust (computing a difference score comparing trust after the baseline vs. after the test. We expect to find less trust behavior decrease after the test block in the 80% baseline block condition for children who receive oxytocin (Study 1). For the other children, we predict stronger decreases in trust behavior (Study 1)., To assess the effect of oxytocin on trust behaviour, we will analyze the changes in self-reported trust (computing a difference score comparing trust after the baseline vs. a

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026